{"id":"NCT01451385","sponsor":"Mallinckrodt","briefTitle":"Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain","officialTitle":"An Open Label Safety Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-20","primaryCompletion":"2012-06-18","completion":"2012-06-18","firstPosted":"2011-10-13","resultsPosted":"2020-09-17","lastUpdate":"2020-09-18"},"enrollment":376,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis","Low Back Pain"],"interventions":[{"type":"DRUG","name":"COV795","otherNames":["MNK795"]}],"arms":[{"label":"COV795","type":"EXPERIMENTAL"}],"summary":"The primary objective is to demonstrate the safety and tolerability of COV795 with up to 35 days use as evaluated by physical exam, vital signs, pulse oximetry, clinical laboratory tests, and other adverse events (AEs).","primaryOutcome":{"measure":"Summary of Adverse Events (AEs)","timeFrame":"5 Weeks","effectByArm":[{"arm":"All Participants","deltaMin":235,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":42,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":376},"commonTop":["Nausea","Vomiting","Dizziness","Somnolence","Constipation"]}}